SAVE, Safe Accelerated Venetoclax Escalation: A phase Ib study of obinutuzumab plus venetoclax with daily ramp-up in CLLJennifer L. Crombie, Matthew S. Davids, Jennifer R. Brown et al.|Blood Advances|2026Cited by 0